Please enable JavaScript to continue using this application.

Compare $CLNN vs $INKT | Chartloom

Compare

$CLNN vs $INKT

Clene Inc · Mink Therapeutics Inc

CLNN

Clene Inc

INKT

Mink Therapeutics Inc

Compare $CLNN vs $INKT

Comparing Clene Inc and Mink Therapeutics Inc

CLNNClene Inc

INKTMink Therapeutics Inc

CLNNClene Inc

Market cap

$49M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

176.51x

Rev growth (TTM)

-31.1%

YTD performance

-33.1%

52W performance

-59.0%

FCF yield

-32.3%

INKTMink Therapeutics Inc

Market cap

$53M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-3.6%

52W performance

-26.5%

FCF yield

-12.8%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

CLNN

INKT

Detailed metrics comparison

CLNN

Clene Inc

INKT

Mink Therapeutics Inc

Market Cap

CLNN$49M

INKT$53M

Enterprise Value

CLNN$58M

INKT$45M

Price

CLNN$3.86

INKT$10.72

P/E Ratio

CLNNN/A

INKTN/A

P/S Ratio

CLNN250.41x

INKT0.00x

EV/Sales

CLNN296.36x

INKT0.00x

EV/EBITDA

CLNN0.00x

INKT0.00x

P/B Ratio

CLNN13.60x

INKT9.40x

P/FCF Ratio

CLNNN/A

INKTN/A

EV/FCF

CLNN-3.66x

INKT-6.53x

PEG Ratio

CLNNN/A

INKTN/A

Forward P/E (NTM)

CLNNN/A

INKTN/A

Forward P/S (NTM)

CLNN176.51x

INKTN/A

Revenue (TTM)

CLNN$197K

INKT$0

Revenue Growth (YoY)

CLNN-31.1%

INKTN/A

Forward Rev Growth

CLNN10485.4%

INKT17.6%

Gross Margin (TTM)

CLNN70.1%

INKT0.0%

Operating Margin (TTM)

CLNN0.0%

INKT0.0%

EBITDA Margin (TTM)

CLNN-9704.6%

INKT0.0%

Net Margin (TTM)

CLNN-20059.9%

INKT0.0%

FCF Margin (TTM)

CLNN-8094.9%

INKTN/A

Net Income (TTM)

CLNN$-40M

INKT$-11M

FCF (TTM)

CLNN$-16M

INKT$-7M

EPS (TTM)

CLNN-$3.19

INKT-$2.26

ROE (TTM)

CLNN-32223.0%

INKT-16887.0%

ROA (TTM)

CLNN-18564.0%

INKT-9237.0%

ROIC (TTM)

CLNN-11721.0%

INKT-16887.0%

Cash

CLNN$10M

INKT$9M

Debt

CLNN$19M

INKT$0

Net Cash/Debt

CLNN$-9M

INKT$9M

Current Ratio (TTM)

CLNN3.07x

INKT1.23x

Quick Ratio (TTM)

CLNN2.91x

INKT1.19x

Debt/Equity (TTM)

CLNN6.36x

INKT0.00x

Debt/Assets (TTM)

CLNN0.0%

INKT0.0%

Interest Coverage (TTM)

CLNNN/A

INKTN/A

Net Debt/EBITDA (TTM)

CLNN0.00x

INKT0.00x

Beta

CLNN1.06

INKT0.45

52W Performance

CLNN-59.0%

INKT-26.5%

YTD Performance

CLNN-33.1%

INKT-3.6%

% from 52W High

CLNN-71.4%

INKT-36.7%

% from 52W Low

CLNN18.8%

INKT26.4%

Asset Turnover (TTM)

CLNN0.01x

INKT0.00x

FCF Yield (TTM)

CLNN-32.3%

INKT-12.8%

Earnings Yield (TTM)

CLNN-80.1%

INKT-21.3%

Dividend Yield (TTM)

CLNNN/A

INKTN/A

Rule of 40

CLNN-8,126.0

INKT0.0

EV/GP/RG

CLNN10.10

INKTN/A

Ticker research

View CLNN research View INKT research

Metric	CLNN Clene Inc	INKT Mink Therapeutics Inc
Market & Valuation
Market Cap	$49M	$53M
Enterprise Value	$58M	$45M
Price	$3.86	$10.72
P/E Ratio	N/A	N/A
P/S Ratio	250.41x	0.00x
EV/Sales	296.36x	0.00x
EV/EBITDA	0.00x	0.00x
P/B Ratio	13.60x	9.40x
P/FCF Ratio	N/A	N/A
EV/FCF	-3.66x	-6.53x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	176.51x	N/A
Revenue & Growth
Revenue (TTM)	$197K	$0
Revenue Growth (YoY)	-31.1%	N/A
Forward Rev Growth	10485.4%	17.6%
Profitability
Gross Margin (TTM)	70.1%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-9704.6%	0.0%
Net Margin (TTM)	-20059.9%	0.0%
FCF Margin (TTM)	-8094.9%	N/A
Net Income (TTM)	$-40M	$-11M
FCF (TTM)	$-16M	$-7M
EPS (TTM)	-$3.19	-$2.26
ROE (TTM)	-32223.0%	-16887.0%
ROA (TTM)	-18564.0%	-9237.0%
ROIC (TTM)	-11721.0%	-16887.0%
Financial Health
Cash	$10M	$9M
Debt	$19M	$0
Net Cash/Debt	$-9M	$9M
Current Ratio (TTM)	3.07x	1.23x
Quick Ratio (TTM)	2.91x	1.19x
Debt/Equity (TTM)	6.36x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.06	0.45
52W Performance	-59.0%	-26.5%
YTD Performance	-33.1%	-3.6%
% from 52W High	-71.4%	-36.7%
% from 52W Low	18.8%	26.4%
Efficiency & Yields
Asset Turnover (TTM)	0.01x	0.00x
FCF Yield (TTM)	-32.3%	-12.8%
Earnings Yield (TTM)	-80.1%	-21.3%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-8,126.0	0.0
EV/GP/RG	10.10	N/A
Ticker research	View CLNN research	View INKT research

Valuation

P/S Ratio

INKT

0.00x

CLNN

250.41x

EV/FCF

INKT

-6.53x

CLNN

-3.66x

Growth & revenue

Revenue Growth TTM

CLNN

-31.1%

Forward Revenue Growth

CLNN

10485.4%

INKT

17.6%

Profitability & performance

Gross Margin

CLNN

70.1%

INKT

0.0%

ROE

INKT

-16887.0%

CLNN

-32223.0%

FCF Yield %

INKT

-12.8%

CLNN

-32.3%

52-Week Performance

INKT

-26.5%

CLNN

-59.0%

Detailed metrics comparison

CLNN

Clene Inc

INKT

Mink Therapeutics Inc

Market Cap

CLNN$49M

INKT$53M

Enterprise Value

CLNN$58M

INKT$45M

Price

CLNN$3.86

INKT$10.72

P/E Ratio

CLNNN/A

INKTN/A

P/S Ratio

CLNN250.41x

INKT0.00x

EV/Sales

CLNN296.36x

INKT0.00x

EV/EBITDA

CLNN0.00x

INKT0.00x

P/B Ratio

CLNN13.60x

INKT9.40x

P/FCF Ratio

CLNNN/A

INKTN/A

EV/FCF

CLNN-3.66x

INKT-6.53x

PEG Ratio

CLNNN/A

INKTN/A

Forward P/E (NTM)

CLNNN/A

INKTN/A

Forward P/S (NTM)

CLNN176.51x

INKTN/A

Revenue (TTM)

CLNN$197K

INKT$0

Revenue Growth (YoY)

CLNN-31.1%

INKTN/A

Forward Rev Growth

CLNN10485.4%

INKT17.6%

Gross Margin (TTM)

CLNN70.1%

INKT0.0%

Operating Margin (TTM)

CLNN0.0%

INKT0.0%

EBITDA Margin (TTM)

CLNN-9704.6%

INKT0.0%

Net Margin (TTM)

CLNN-20059.9%

INKT0.0%

FCF Margin (TTM)

CLNN-8094.9%

INKTN/A

Net Income (TTM)

CLNN$-40M

INKT$-11M

FCF (TTM)

CLNN$-16M

INKT$-7M

EPS (TTM)

CLNN-$3.19

INKT-$2.26

ROE (TTM)

CLNN-32223.0%

INKT-16887.0%

ROA (TTM)

CLNN-18564.0%

INKT-9237.0%

ROIC (TTM)

CLNN-11721.0%

INKT-16887.0%

Cash

CLNN$10M

INKT$9M

Debt

CLNN$19M

INKT$0

Net Cash/Debt

CLNN$-9M

INKT$9M

Current Ratio (TTM)

CLNN3.07x

INKT1.23x

Quick Ratio (TTM)

CLNN2.91x

INKT1.19x

Debt/Equity (TTM)

CLNN6.36x

INKT0.00x

Debt/Assets (TTM)

CLNN0.0%

INKT0.0%

Interest Coverage (TTM)

CLNNN/A

INKTN/A

Net Debt/EBITDA (TTM)

CLNN0.00x

INKT0.00x

Beta

CLNN1.06

INKT0.45

52W Performance

CLNN-59.0%

INKT-26.5%

YTD Performance

CLNN-33.1%

INKT-3.6%

% from 52W High

CLNN-71.4%

INKT-36.7%

% from 52W Low

CLNN18.8%

INKT26.4%

Asset Turnover (TTM)

CLNN0.01x

INKT0.00x

FCF Yield (TTM)

CLNN-32.3%

INKT-12.8%

Earnings Yield (TTM)

CLNN-80.1%

INKT-21.3%

Dividend Yield (TTM)

CLNNN/A

INKTN/A

Rule of 40

CLNN-8,126.0

INKT0.0

EV/GP/RG

CLNN10.10

INKTN/A

Ticker research

View CLNN research View INKT research

Metric	CLNN Clene Inc	INKT Mink Therapeutics Inc
Market & Valuation
Market Cap	$49M	$53M
Enterprise Value	$58M	$45M
Price	$3.86	$10.72
P/E Ratio	N/A	N/A
P/S Ratio	250.41x	0.00x
EV/Sales	296.36x	0.00x
EV/EBITDA	0.00x	0.00x
P/B Ratio	13.60x	9.40x
P/FCF Ratio	N/A	N/A
EV/FCF	-3.66x	-6.53x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	176.51x	N/A
Revenue & Growth
Revenue (TTM)	$197K	$0
Revenue Growth (YoY)	-31.1%	N/A
Forward Rev Growth	10485.4%	17.6%
Profitability
Gross Margin (TTM)	70.1%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-9704.6%	0.0%
Net Margin (TTM)	-20059.9%	0.0%
FCF Margin (TTM)	-8094.9%	N/A
Net Income (TTM)	$-40M	$-11M
FCF (TTM)	$-16M	$-7M
EPS (TTM)	-$3.19	-$2.26
ROE (TTM)	-32223.0%	-16887.0%
ROA (TTM)	-18564.0%	-9237.0%
ROIC (TTM)	-11721.0%	-16887.0%
Financial Health
Cash	$10M	$9M
Debt	$19M	$0
Net Cash/Debt	$-9M	$9M
Current Ratio (TTM)	3.07x	1.23x
Quick Ratio (TTM)	2.91x	1.19x
Debt/Equity (TTM)	6.36x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.06	0.45
52W Performance	-59.0%	-26.5%
YTD Performance	-33.1%	-3.6%
% from 52W High	-71.4%	-36.7%
% from 52W Low	18.8%	26.4%
Efficiency & Yields
Asset Turnover (TTM)	0.01x	0.00x
FCF Yield (TTM)	-32.3%	-12.8%
Earnings Yield (TTM)	-80.1%	-21.3%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-8,126.0	0.0
EV/GP/RG	10.10	N/A
Ticker research	View CLNN research	View INKT research